- Home
- MCHX vs VTGN Comparison
MCHX vs VTGN Comparison
Compare MCHX & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MCHX | VTGN |
|---|---|---|
| Founded | 2003 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.3M | 21.8M |
| IPO Year | 2003 | 2014 |
Fundamental Metrics
Financial Performance| Metric | MCHX | VTGN |
|---|---|---|
| Price | $1.45 | $0.56 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $0.90 |
| AVG Volume (30 Days) | 10.8K | ★ 471.6K |
| Earning Date | 03-25-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $90,291,000.00 | N/A |
| Revenue This Year | $9.12 | $124.49 |
| Revenue Next Year | N/A | $353.99 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.26 | $0.43 |
| 52 Week High | $2.30 | $5.14 |
Technical Indicators
Market Signals| Indicator | MCHX | VTGN |
|---|---|---|
| Relative Strength Index (RSI) | 48.04 | 40.05 |
| Support Level | $1.35 | $0.50 |
| Resistance Level | $1.76 | $0.60 |
| Average True Range (ATR) | 0.08 | 0.04 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 41.90 | 6.32 |
Price Performance
Historical ComparisonAbout MCHX Marchex Inc. Class B
Marchex Inc provides AI-based conversational intelligence and analytics solutions that generate insights from customer communications data. The company's products support sales, marketing, and executive teams in analyzing customer interactions across communication channels and informing business decisions. It serves companies operating in business-to-business-to-consumer (B2B2C) markets across multiple industries like automotive, home services, healthcare, real estate, and advertising. The company operates in a single segment: conversational analytics and related solutions. The company generates the majority of revenue from its conversational intelligence product offerings. Geographically, it generates the maximum revenue from the United States.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.